Jessica Lovett is Vice President, Commercial Strategy and Innovation for Innomar Strategies, where she oversees business development, innovative partnerships, stakeholder relations, and commercialization across the Canadian business.

A commercial and innovation strategist with expertise in growing and developing both brands and people. With over twenty five years of pharmaceutical commercialization experience, Jessica leads vision, strategic prioritization and growth / diversification for Canada. Jessica joined Innomar Strategies (a part of Cencora) in 2015, focusing on healthcare market trends and navigating lifecycle solutions for new specialty companies and existing portfolio expansions in the Canadian market. Since then, her role has expanded to include oversight of the company’s innovative partnerships and overall commercial strategy across stakeholder channels.

Before joining Innomar, Jessica held senior roles in commercial leadership for GlaxoSmithKline across multiple therapeutic areas, including respiratory and vaccines. Her experience extended through national public tender and direct-to-consumer (DTC) global and local capabilities, along with stakeholder relations and integrated multi-channel marketing. Jessica has a deep understanding of the customer journey and future market pipeline trends for pharma and biotech companies.